| Application no. and date | 02709050.5 (espacenet) (Federated) (European Patent Register), 20020125 | | Patent/reg. no. and date | DK/EP 1355644, 20060628 | | Publication date | 20031029 | | Priority no. and date | US 264645 P, 20010126 | | EP pub. no. and date |
EP 1355644 20031029 | | Effective date | | | Applicant/owner | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue
Rayway, New Jersey 07065, US | | Applicant ref. no. | 150407 | | Inventor | DAVIS, Harry, R., 64 River Bend Road
Berkeley Heights, NJ 07922, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/397 (2006.01) , A61P 3/06 (2006.01) , A61P 9/10 (2006.01) | | Title | Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi | | Int. application no. | US2002001195 | | Int. publication no. | WO2002058696 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
